Free Standard AU & NZ Shipping For All Book Orders Over $80!
Register      Login
Sexual Health Sexual Health Society
Publishing on sexual health from the widest perspective
RESEARCH ARTICLE

Perceptions of sexually transmissible infection pre-exposure prophylaxis: a qualitative study of high-risk gay and bisexual men in Sydney, New South Wales

Ryan Horn A , Denton Callander https://orcid.org/0000-0002-4116-4250 B C and Bridget Haire B D
+ Author Affiliations
- Author Affiliations

A UNSW Medicine, UNSW Sydney, Sydney, NSW 2052, Australia.

B The Kirby Institute, UNSW Sydney, Sydney, NSW 2052, Australia.

C Columbia University Mailman School of Public Health, Columbia University, New York, NY 10032, USA.

D Corresponding author. Email: b.haire@unsw.edu.au

Sexual Health 17(2) 129-134 https://doi.org/10.1071/SH19175
Submitted: 10 October 2019  Accepted: 9 December 2019   Published: 26 March 2020

Abstract

Background: Novel sexually transmissible infection (STI) prevention strategies are needed to combat increasing bacterial STI incidences alongside decreasing condom use among gay and bisexual men (GBM) in Australia. Sexually transmissible infection pre-exposure prophylaxis (STI-PrEP) using regular doxycycline is one such strategy that is the subject of ongoing research. However, a lack of qualitative data regarding the conceptualisation, perceived risks, perceived benefits and preferred dosing strategies of STI-PrEP may impede future research and implementation efforts. Methods: Semistructured in-depth interviews were conducted with 13 high-risk GBM residing in Sydney, Australia. Interviews were audio recorded, transcribed verbatim and then analysed thematically. Results: STI-PrEP was largely conceptualised using pre-existing knowledge of HIV-PrEP. The perceived benefits, including a reduced incidence of STIs, destigmatisation and a ‘peace of mind’, often outweighed the perceived risks, including side effects, antibiotic resistance and stigmatisation of consumers. A daily dosing regimen was preferred unanimously by participants when compared with event-driven or episodic strategies. Conclusions: Participants of this study were cautiously optimistic regarding the concept of STI-PrEP. The findings suggest that, in addition to examining the effectiveness of STI-PrEP, future implementation studies should also focus on concerns regarding side effects and monitoring antibiotic resistance, as well as considering the acceptability and potential for stigmatisation of STI-PrEP consumers.

Additional keywords: antibiotics, prevention, syphilis.


References

[1]  The Kirby Institute. HIV, viral hepatitis and sexually transmissible infections in Australia – annual surveillance report 2012. Sydney: UNSW Sydney; 2012.

[2]  The Kirby Institute. Annual surveillance report 2018 – HIV, viral hepatitis and sexually transmissible infections in Australia. Sydney: UNSW Sydney; 2018.

[3]  Mao L, Holt M, Newman C, Treloar C. Annual report of trends in behaviour 2018 – HIV and STIs in Australia. Sydney: Centre for Social Research in Health, UNSW Sydney; 2018.

[4]  Grant JS, Stafylis C, Celum C, Grennan T, Haire B, Kaldor J, et al. Doxycycline prophylaxis for bacterial sexually transmitted infections. Clin Infect Dis 2019; 70 ciz866
Doxycycline prophylaxis for bacterial sexually transmitted infections.Crossref | GoogleScholarGoogle Scholar |

[5]  Bolan RK, Beymer MR, Weiss RE, Flynn RP, Leibowitz AA, Klausner JD. Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study. Sex Transm Dis 2015; 42 98–103.
Doxycycline prophylaxis to reduce incident syphilis among HIV-infected men who have sex with men who continue to engage in high-risk sex: a randomized, controlled pilot study.Crossref | GoogleScholarGoogle Scholar | 25585069PubMed |

[6]  Grennan T. Oral doxycycline for the prevention of syphilis in men who have sex with men (DaDHS). NCT0286455. ClinicalTrials.gov; 2016. Available online at: https://clinicaltrials.gov/ct2/show/NCT02864550?term=Doxycycline+prophylaxis&cond=STI&rank=1 [verified 4 April 2019].

[7]  Lu S, Haire B. Impact of the daily doxycycline pre-exposure prophylaxis (PrEP) on the incidence of syphilis, gonorrhoea and chlamydia (Syphilaxis). NCT03709459. ClinicalTrials.gov; 2018. Available online at: https://clinicaltrials.gov/ct2/show/NCT03709459 [verified 9 June 2019].

[8]  Chow EPF, Fairley CK. Use of doxycycline prophylaxis among gay and bisexual men in Melbourne. Lancet HIV 2019; 6 e568–9.
Use of doxycycline prophylaxis among gay and bisexual men in Melbourne.Crossref | GoogleScholarGoogle Scholar | 31498105PubMed |

[9]  Wilson DP, Prestage GP, Gray RT, Hoare A, McCann P, Down I, et al. Chemoprophylaxis is likely to be acceptable and could mitigate syphilis epidemics among populations of gay men. Sex Transm Dis 2011; 38 573–9.
Chemoprophylaxis is likely to be acceptable and could mitigate syphilis epidemics among populations of gay men.Crossref | GoogleScholarGoogle Scholar | 21343845PubMed |

[10]  O’Reilly M. On demand post exposure prophylaxis with doxycycline for MSM enrolled in a PrEP trial. ASHM Report Back; 2017. Available online at: http://ashm.info/report-back/on-demand-post-exposure-prophylaxis-with-doxycycline-for-msm-enrolled-in-a-prep-trial [verified 4 April 2019].

[11]  Siguier M, Molina J-M. Doxycycline prophylaxis for bacterial sexually transmitted infections: promises and perils. ACS Infect Dis 2018; 4 660–3.
Doxycycline prophylaxis for bacterial sexually transmitted infections: promises and perils.Crossref | GoogleScholarGoogle Scholar | 29570279PubMed |

[12]  Minichiello V, Aroni R, Hays T. In-depth interviewing: principles, techniques, analysis. 3rd edn. Sydney: Pearson Education Australia; 2008.

[13]  Braun V, Clarke V. Successful qualitative research: a practical guide for beginners. London: SAGE Publications; 2013.

[14]  Braun V, Clarke V. Using thematic analysis in psychology. Qual Res Psychol 2006; 3 77–101.
Using thematic analysis in psychology.Crossref | GoogleScholarGoogle Scholar |

[15]  Molina J-M, Charreau I, Chidiac C, Pialoux G, Cua E, Delaugerre C, et al. Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial. Lancet Infect Dis 2018; 18 308–17.
Post-exposure prophylaxis with doxycycline to prevent sexually transmitted infections in men who have sex with men: an open-label randomised substudy of the ANRS IPERGAY trial.Crossref | GoogleScholarGoogle Scholar | 29229440PubMed |

[16]  Spinelli MA, Scott HM, Vittinghoff E, Liu AY, Coleman K, Buchbinder SP. High interest in doxycycline for sexually transmitted infection postexposure prophylaxis in a multicity survey of men who have sex with men using a social networking application. Sex Transm Dis 2019; 46 e32–4.
High interest in doxycycline for sexually transmitted infection postexposure prophylaxis in a multicity survey of men who have sex with men using a social networking application.Crossref | GoogleScholarGoogle Scholar | 30870327PubMed |

[17]  Liu A, Cohen S, Follansbee S, Cohan D, Weber S, Sachdev D, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med 2014; 11 e1001613
Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco.Crossref | GoogleScholarGoogle Scholar | 24595035PubMed |

[18]  Phillips MA, Kass RB. User acceptability patterns for mefloquine and doxycycline malaria chemoprophylaxis. J Travel Med 1996; 3 40–5.
User acceptability patterns for mefloquine and doxycycline malaria chemoprophylaxis.Crossref | GoogleScholarGoogle Scholar | 9815421PubMed |

[19]  Dubourg G, Raoult D. The challenges of preexposure prophylaxis for bacterial sexually transmitted infections. Clin Microbiol Infect 2016; 22 753–6.
The challenges of preexposure prophylaxis for bacterial sexually transmitted infections.Crossref | GoogleScholarGoogle Scholar | 27585939PubMed |

[20]  Vaccher SJ, Gianacas C, Templeton DJ, Poynten IM, Haire BG, Ooi C, et al. Baseline preferences for daily, event-driven, or periodic HIV pre-exposure prophylaxis among gay and bisexual men in the PRELUDE demonstration project. Front Public Health 2017; 5 341
Baseline preferences for daily, event-driven, or periodic HIV pre-exposure prophylaxis among gay and bisexual men in the PRELUDE demonstration project.Crossref | GoogleScholarGoogle Scholar | 29326917PubMed |

[21]  Jung M. Sexual behavior and condom use among gay men, female sex workers, and their customers: evidence from South Korea. PLoS One 2013; 8 e66867
Sexual behavior and condom use among gay men, female sex workers, and their customers: evidence from South Korea.Crossref | GoogleScholarGoogle Scholar | 24386354PubMed |

[22]  Weeks J. The sexual citizen. Theory Cult Soc 1998; 15 35–52.
The sexual citizen.Crossref | GoogleScholarGoogle Scholar |